MOTS-c: Your Mitochondria’s Hidden Immune Defense?

New research suggests the mitochondrial-encoded peptide MOTS-c may participate in an ancient form of innate immune defense.

MOTS-c: Your Mitochondria’s Hidden Immune Defense?

Every human cell carries two genetic libraries.

The large and familiar one is DNA stored inside the nucleus. The other is a tiny circular genome tucked inside the mitochondria, the structures best known for helping cells produce energy.

That second genome is a relic of one of evolution’s strangest partnerships.

Billions of years ago, an ancestral cell absorbed a free-living bacterium. Instead of destroying one another, the two formed a permanent alliance. The bacterium gradually became the mitochondrion, but it never surrendered all of its DNA.

A newly published paper in eLife suggests that this leftover bacterial genome may be doing something far more interesting than helping run cellular metabolism. It may still encode a direct form of immune protection.

At the center of the story is MOTS-c, a tiny mitochondrial peptide usually discussed in connection with metabolic health, cellular stress, exercise, and aging.

The new research proposes a much broader identity: MOTS-c may also function as a mitochondrial-encoded host-defense peptide.

That would mean part of our innate immune system may be written not only in the DNA inside the nucleus, but also in the genome of an ancient bacterium still living inside nearly every cell in the body.

MOTS-c Was Supposed to Be a Metabolic Story

MOTS-c was identified in 2015 as a 16-amino-acid peptide encoded within mitochondrial DNA. Its full name, mitochondrial open reading frame of the 12S ribosomal RNA type-c, is less memorable than its abbreviation.

Early research focused heavily on metabolism. In cells and animal models, MOTS-c was linked to insulin sensitivity, metabolic regulation, stress adaptation, and communication between mitochondria and the nucleus.

That last function was particularly unusual. Under metabolic stress, MOTS-c appeared capable of moving into the nucleus and influencing the expression of genes involved in cellular adaptation.

This helped change the way researchers viewed mitochondria. Rather than serving only as cellular power plants, mitochondria appeared able to produce signaling molecules that carried instructions to other parts of the cell.

Online discussion took those findings much further. MOTS-c became associated with sweeping claims involving fat loss, endurance, recovery, muscle function, healthy aging, and longevity. Most of those claims extend well beyond what has been demonstrated in humans.

The new eLife paper does not validate that marketing. Instead, it opens an entirely different scientific door.

What Is a Host-Defense Peptide?

MOTS-c contains positively charged and hydrophobic regions that may help it bind to and disrupt bacterial membranes under laboratory conditions.

Host-defense peptides are short proteins produced by living organisms as part of their built-in protection against microbes.

They are sometimes called antimicrobial peptides, but many do more than directly attack bacteria. They can also help recruit immune cells, regulate inflammation, influence tissue repair, and shape how immune cells respond to a threat.

They are part of innate immunity, the body’s fast, general-purpose defense system. Unlike antibodies, which recognize specific targets after exposure, innate immune defenses respond quickly to broad signs of infection or injury.

Many host-defense peptides share two structural traits. They are cationic, meaning they carry a positive electrical charge, and amphipathic, meaning they contain both water-attracting and fat-attracting regions.

That combination is useful against bacteria.

Bacterial surfaces commonly carry a negative charge, which can attract a positively charged peptide. Once the peptide reaches the bacterium, its hydrophobic region can interact with the fatty bacterial membrane. This may destabilize the membrane, cause leakage, interfere with cellular functions, or make the bacterium easier for immune cells to eliminate.

MOTS-c has both features. It contains a positively charged tail and a hydrophobic core.

That structural resemblance led researchers to ask an unexpected question: Could a peptide known for metabolic signaling also behave like an ancient immune-defense molecule?

MOTS-c Directly Targeted Bacteria in the Laboratory

The researchers first tested whether MOTS-c could physically interact with bacteria.

In laboratory experiments, MOTS-c rapidly associated with Escherichia coli and methicillin-resistant Staphylococcus aureus, better known as MRSA. Imaging showed damaged bacterial membranes and changes consistent with reduced bacterial viability.

The structure of MOTS-c appeared essential to that activity. When researchers altered either its hydrophobic core or its positively charged region, much of the antibacterial effect was lost. Increasing the salt concentration also weakened its ability to aggregate bacteria, which supports the idea that electrical attraction contributed to the interaction.

This is a compelling mechanism. The positively charged region appears to help MOTS-c recognize and bind to bacterial surfaces, while the hydrophobic region helps disturb the membrane.

It is not evidence that MOTS-c is a clinically useful antibiotic.

These experiments placed peptide and bacteria together under controlled laboratory conditions. The effects depended partly on concentration, proximity, salt conditions, and the ratio of MOTS-c to bacteria. A peptide disrupting bacteria in a dish does not tell us whether it could reach an infection inside the human body, remain stable long enough to work, avoid unintended effects, or achieve an effective concentration safely.

The finding identifies a biological capability. It does not establish a treatment.

The Immune Cells Started Making More MOTS-c

The paper became more interesting when researchers looked at monocytes.

Monocytes are circulating immune cells that patrol the bloodstream. When they enter tissues and encounter the right signals, they can mature into macrophages. Macrophages are cellular first responders that engulf microbes, clear damaged material, release signaling molecules, and help coordinate the wider immune response.

Researchers found that human monocytes increased their production of MOTS-c when exposed to several immune and developmental signals.

One was interferon-gamma, a signaling protein used by the immune system to activate antimicrobial defenses. Another was lipopolysaccharide, or LPS, a component of the outer membrane of certain bacteria. MOTS-c also increased as monocytes received signals directing them to mature into macrophages.

This matters because it suggests MOTS-c was not merely capable of harming bacteria when added artificially. Human immune cells appeared to produce more of their own MOTS-c when they encountered signals associated with infection and immune activation.

That pattern is consistent with an endogenous immune role, meaning a function that naturally exists within the body.

It still does not prove how important MOTS-c is during a real human infection. Much of the detailed human-cell work relied on THP-1 cells, a laboratory cell line commonly used to study monocytes and macrophages. The researchers also included primary human monocytes, but the paper’s peer reviewers specifically noted that more confirmation in primary cells is needed.

MOTS-c Changed How Macrophages Developed

The researchers then asked whether MOTS-c could do more than interact directly with bacteria.

When MOTS-c was present while monocytes developed into macrophages, it altered their trajectory. The resulting macrophages showed different patterns of gene expression involving antigen presentation, interferon signaling, inflammation, and metabolism.

In plain language, MOTS-c appeared to help program the developing immune cells into a distinct functional state.

Those macrophages also demonstrated greater bacterial clearance in laboratory experiments. The findings suggest a possible two-part defense strategy: MOTS-c may interact directly with bacteria while also influencing the immune cells responsible for clearing them.

This combination is characteristic of many host-defense peptides. They do not behave simply like chemical weapons. They can also act as immune signals, changing how cells prepare for and respond to microbial threats.

The metabolic changes observed in the macrophages may also help connect the new findings with the older MOTS-c literature.

Immune cells must rapidly reorganize how they produce and use energy when they become activated. Metabolism and immunity are not separate systems. An immune cell’s metabolic state helps determine what that cell can do.

A peptide originally studied as a metabolic regulator may therefore have appeared metabolic partly because metabolism is one of the tools cells use to mount a defense.

What Happened in the Mouse Experiment?

The mouse study tested MRSA that had been placed in direct contact with MOTS-c before exposure, not MOTS-c administered after an infection was established.

The researchers also tested MOTS-c in a mouse model involving acute exposure to MRSA.

This part of the study requires careful explanation.

The MRSA was resuspended with MOTS-c before being introduced into the mice. The bacteria and peptide were therefore placed in direct contact before the animals were exposed. Under those conditions, MOTS-c neutralized the infectivity of the MRSA preparation and dramatically improved survival.

That is a striking proof-of-concept result. It shows that MOTS-c can affect bacterial infectivity in a living-animal experiment.

It was not a test of administering MOTS-c after an infection had become established. It did not evaluate whether injected MOTS-c could locate an infection, reach an effective tissue concentration, or rescue an animal after disease progression had begun.

Calling this an infection treatment study would misrepresent what the researchers did.

Why the Mitochondrial Origin Matters

The most fascinating part of this discovery may not be the bacterial killing. It may be where the peptide comes from.

The human mitochondrial genome is extremely small compared with nuclear DNA. Most genes needed to build and operate mitochondria moved into the nucleus over evolutionary time. The mitochondrial genome retained only a compact set of genetic instructions, along with short reading frames that researchers have only recently begun to investigate.

MOTS-c is encoded within one of those mitochondrial regions.

The authors propose that its host-defense characteristics may reflect the bacterial ancestry of mitochondria. Ancient bacteria used small peptides to compete, communicate, regulate growth, and defend themselves. A peptide descended from that biology may have been retained as the bacterium evolved into a permanent cellular partner.

If that interpretation is correct, our cells may have preserved an ancient bacterial defense system and incorporated it into human immunity.

The immune system is traditionally described as a product of nuclear genes. This paper raises the possibility that the mitochondrial genome contributes active immune factors of its own.

MOTS-c may be the first identified example, not necessarily the only one.

What This Study Does Not Prove

This research does not show that externally supplied MOTS-c prevents or treats infections in humans.

It does not establish human effectiveness, safety, pharmacokinetics, tissue exposure, an appropriate concentration, or any treatment protocol. It does not show that MOTS-c can replace antibiotics, overcome antibiotic resistance in patients, or treat MRSA after an infection has developed.

MOTS-c should not be called an antibiotic on the basis of this paper.

The study also does not validate the broad metabolic, performance, recovery, anti-aging, or longevity claims commonly attached to MOTS-c online. Those are separate questions requiring their own evidence.

What the paper does provide is solid preclinical evidence that MOTS-c has structural and functional characteristics associated with host-defense peptides. It directly interacted with bacteria, influenced monocyte-to-macrophage development, enhanced bacterial clearance by those cells, and reduced MRSA infectivity under a specific mouse-experiment design.

Those findings are scientifically important without being treated as clinical proof.

A Much Bigger Question Is Now Open

MOTS-c has spent most of its scientific life categorized as a mitochondrial and metabolic signaling peptide.

That category may have been too narrow.

The new research suggests MOTS-c could sit at the intersection of metabolism, cellular stress, and innate immunity. Its metabolic effects and immune effects may not represent unrelated functions. They may be different parts of the same ancient system for helping cells survive threats.

The most important outcome of this paper is not a new infection treatment. It is a new way of thinking about what mitochondria still contribute to human biology.

The small genome inside them may not be a fading genetic souvenir. It may retain active defenses inherited from the bacteria that helped make complex life possible.

MOTS-c may be one of those defenses.

That possibility is far more interesting than another exaggerated peptide claim. It changes the question from “What can people use MOTS-c for?” to something much more fundamental:

What else has the mitochondrial genome been quietly doing all along?

References

1. Rice MC, Imun M, Jung SW, et al. MOTS-c Is a Mitochondrial-Encoded Interferon-Linked Host Defense Peptide. eLife. Published August 18, 2026;12:RP87615.https://pubmed.ncbi.nlm.nih.gov/42611943/https://pmc.ncbi.nlm.nih.gov/articles/PMC13485304/https://doi.org/10.7554/eLife.87615

2. Lee C, Zeng J, Drew BG, et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism. 2015;21(3):443–454.https://pubmed.ncbi.nlm.nih.gov/25738459/

3. Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism. 2018;28(3):516–524.e7.https://pubmed.ncbi.nlm.nih.gov/29983246/

4. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis. Nature Communications. 2021;12(1):470.https://pubmed.ncbi.nlm.nih.gov/33473109/

5. Mottis A, Herzig S, Auwerx J. Mitocellular Communication: Shaping Health and Disease. Science. 2019;366(6467):827–832.https://pubmed.ncbi.nlm.nih.gov/31727828/

6. West AP, Shadel GS. Mitochondrial DNA in Innate Immune Responses and Inflammatory Pathology. Nature Reviews Immunology. 2017;17(6):363–375.https://pubmed.ncbi.nlm.nih.gov/28393922/

7. West AP, Khoury-Hanold W, Staron M, et al. Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response. Nature. 2015;520(7548):553–557.https://pubmed.ncbi.nlm.nih.gov/25642965/

8. Roger AJ, Muñoz-Gómez SA, Kamikawa R. The Origin and Diversification of Mitochondria. Current Biology. 2017;27(21):R1177–R1192.https://pubmed.ncbi.nlm.nih.gov/29112874/

9. Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ. Antimicrobial Host Defence Peptides: Functions and Clinical Potential. Nature Reviews Drug Discovery. 2020;19(5):311–332.https://pubmed.ncbi.nlm.nih.gov/32107480/

10. Hancock REW, Sahl HG. Antimicrobial and Host-Defense Peptides as New Anti-Infective Therapeutic Strategies. Nature Biotechnology. 2006;24(12):1551–1557.https://doi.org/10.1038/nbt1267

11. Kumar P, Kizhakkedathu JN, Straus SK. Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo. Biomolecules. 2018;8(1):4.https://pubmed.ncbi.nlm.nih.gov/29351202/

12. Guilliams M, Mildner A, Yona S. Developmental and Functional Heterogeneity of Monocytes. Immunity. 2018;49(4):595–613.https://pubmed.ncbi.nlm.nih.gov/30332628/

13. Riksen NP, Stienstra R. Metabolism of Innate Immune Cells: Impact on Atherosclerosis. Current Opinion in Lipidology. 2018;29(5):359–367.https://pubmed.ncbi.nlm.nih.gov/30020200/

14. Kong BS, Min SH, Lee C, Cho YM. Mitochondrial-Encoded MOTS-c Prevents Pancreatic Islet Destruction in Autoimmune Diabetes. Cell Reports. 2021;36(9):109447.https://pubmed.ncbi.nlm.nih.gov/34320351/

Disclaimer

This article is for educational and informational purposes only and is not medical advice. The research discussed is preclinical and does not establish that MOTS-c can prevent, diagnose, or treat infection or any other condition in humans. It does not establish clinical effectiveness, human safety, an appropriate exposure level, or any therapeutic protocol.

BioBond Labs™ products are intended for research use only and are not for human or veterinary consumption.